Respiratory measures in amyotrophic lateral sclerosis

Area of Science:

• Neurology
• Pulmonology
• Clinical Medicine

Background:

• Amyotrophic lateral sclerosis (ALS) is a progressive neuromuscular disease leading to respiratory failure and death within 3-5 years.
• Effective management of ALS necessitates vigilant monitoring of respiratory status.
• Pulmonary function tests (PFTs) are vital for clinical decision-making, including the timing of noninvasive ventilation initiation.

Purpose of the Study:

• To review and describe tests used for assessing respiratory muscle and pulmonary function in ALS patients.
• To explore the correlations between various respiratory measures and clinical outcomes in ALS.
• To aid in determining the most suitable PFTs for different stages of ALS progression and clinical decisions.

Main Methods:

• Systematic review of literature on respiratory and pulmonary function tests in ALS.
• Analysis of correlations between different respiratory measures and clinical outcomes.
• Evaluation of the advantages and disadvantages of various PFTs.

Main Results:

• Forced vital capacity (VC) is a common measurement correlating with survival but requires patient cooperation and specific physical capabilities.
• Alternative tests like slow VC, sniff inspiratory pressure, and transdiaphragmatic pressure offer different insights but have unique limitations.
• Each test presents distinct benefits and drawbacks in assessing respiratory function in ALS.

Conclusions:

• The optimal application and timing of different PFTs in ALS management remain subjects for further clarification.
• Understanding the relationship between specific tests, disease progression, and survival is key to selecting appropriate assessments.
• Informed selection of PFTs can enhance clinical decision-making and patient care in amyotrophic lateral sclerosis.